← Evidence map

ArticleFrontiers in oncology2022

HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma.

Fengling Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36324576